BioSpace News Archive

BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA.

HuidaGene Therapeutics today announced the U.S. Food and Drug Administration (FDA) had granted both the Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to HG204 for the treatment of MECP2 duplication syndrome (MDS), a rare and fatal childhood neurodevelopmental disorder for which there is no treatment.

Ortho Development Corporation, a designer and manufacturer of orthopedic implants and instruments for hip and knee joint replacement surgery, today announced the launch of BKS® Uni, the latest addition to its portfolio of Balanced Knee® implant systems.

Lucid Diagnostics Inc. today announced that it will host a business update conference call and webcast on Tuesday, November 14, 2023, at 8:30 AM EST.

Linkam Scientific Instruments showcased its range of market-leading temperature and environmental control microscopy stages – the DSC450, THMS600, and MFS – at this year’s Advanced Materials Show (AMS) in Columbus, Ohio.

Indaptus Therapeutics, Inc. (Nasdaq: INDP) announces it will be presenting interim data from the first cohort of four patients in the Phase 1 INDP-D101 trial of its lead compound, Decoy20.

Lyell Immunopharma, Inc. is presenting new nonclinical data at the 38th Annual Meeting of the Society for Immunotherapy of Cancer.

Context Therapeutics Inc. today announced encouraging preclinical data regarding the Company’s preclinical asset, CTIM-76, a Claudin 6 (CLDN6) x CD3 T-cell engaging bispecific antibody.

Vaccinex, Inc. will be reporting novel findings for its lead product, pepinemab, in two presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held in San Diego, CA November 1-5, 2023.

Gracell Biotechnologies Inc. announced today preclinical data from the Company’s SMART CART™* technology for solid tumors will be presented as a poster at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, taking place November 1-5, 2023, in San Diego and online.